SHELTON — Cara Therapeutic Inc., a biotechnology company that moved to town a year ago from New York, has received a $12.3 million boost from investors — money that will allow the company to begin testing two of its pain-relieving drugs on patients.
SHELTON — Cara Therapeutic Inc., a biotechnology company that moved to town a year ago from New York, has received a $12.3 million boost from investors — money that will allow the company to begin testing two of its pain-relieving drugs on patients.
